This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

Completed · Phase 4

Conditions studied: Diabetes Mellitus, Type 2

In brief

This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.

Key facts

Study ID

NCT00418522

Run by

Pfizer

People needed

413

Starts

2007-03-01

Expected to finish

2008-08-01

Last updated by the study team

2018-09-28

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 30 years and ≤ 75 years with a diagnosis of type 2 diabetes mellitus made > 6 months prior to study entry
• Screening HbA1c > 7.0%
• Currently treated on a stable dose of at least 2 oral antidiabetic agents for at least 3 months prior to study entry; including a sulfonylurea and/or metformin, and/or a thiazolidinedione

You may not qualify if…

• Smoking within last 6 months PFTs outside of range
• Type 1 diabetes mellitus
• Type 2 diabetes mellitus currently (last three months) treated with an insulin regimen (alone or with Oral Antidiabetic Agents)
• Active liver disease; significantly-impaired hepatic function, as shown by, but not limited to, alanine aminotransferase (ALT) serum glutamic pyruvic transaminase (SGPT) or aspartate transaminase (AST) serum glutamic-oxaloacetic transaminase (SGOT) above 2x the upper limit of normal as measured at visit 1. However, patients with elevated ALT >1.5 upper limit of normal as a result of hepatic steatosis are permitted to enter the study.

Where it is running

• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Concord, California, United States
• Pfizer Investigational Site — Encino, California, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Fullerton, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Mission Viejo, California, United States
• Pfizer Investigational Site — Pasadena, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — San Luis Obispo, California, United States
• Pfizer Investigational Site — Spring Valley, California, United States
• Pfizer Investigational Site — Stockton, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — West Hills, California, United States
• Pfizer Investigational Site — Golden, Colorado, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Newark, Delaware, United States
• Pfizer Investigational Site — Chiefland, Florida, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — Hollywood, Florida, United States
• Pfizer Investigational Site — Kissimmee, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.